CLINICAL_TRIALS
trial_result
· 2022-05-06
Clinical Trial Update: The Efficacy of Dietary Flaxseed for the Reduction of Blood Pressure in Newly Diagnosed Hypertensive Individuals [Phase 2, Phase 3]
Summary
Trial update on dietary flaxseed for reducing blood pressure in newly diagnosed hypertension; study terminated after Phase 2/3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: St. Boniface Hospital | Conditions: Hypertension | Phase 2, Phase 3 | Status: TERMINATED